News & Articles

Prof. Akiko Iwasaki explores the differences in the immune responses of COVID-19 patients with moderate and severe disease

A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine

Using cancer biomarkers, the VENTANA MMR RxDx Panel helps determine which tumor patients may benefit from GSK immunotherapy

Adults who have received a double vaccination are 47% less likely to have long COVID

Keep up to date with the latest technologies and techniques advancing clinical diagnostics

Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond

QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes

Patients with underlying heart problems are more than four times as likely to die from COVID-19

The company plans to interface the algorithm into the Atellica Data Manager software in the future

Lab manager Marisa Hildebrandt emphasizes the need for better communication in science and honest product reviews that ‘get past the hype’

Watch this on-demand webinar to gain insights into the design and development pipeline for rapid response solutions

Dr. Tullia Bruno shares her multi-omics approach to investigating the role of B cells and tertiary lymphoid structures in the quest for novel cancer therapies

This week, explore topics ranging from checkpoint inhibitor therapies to TIRF microscopy and automated liquid chromatography

Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy

Continued emergence of SARS-CoV-2 variants highlights importance of sequencing for accurate COVID-19 tracking and surveillance

The Simple Plex AAV2 assay combines the scalability and automation of Ella with best-in-class AAV reagents from PROGEN

The company seeks to become a global centre of excellence for whole genome sequencing

Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc. discusses the cutting-edge technology transforming the identification of new targets for the development of effective immunotherapeutics

Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells